Is There Tachyphylaxis to Intravitreal Anti-Vascular Endothelial Growth Factor Pharmacotherapy in Age-Related Macular Degeneration?
Authors:
- Henry J. KaplanHKHenry J. Kaplan
- Tongalp H. TezelTTTongalp H. Tezel
- 1 December 2008
- journal article
- Published by Elsevier in Ophthalmology
- Vol. 115 (12) , 2199-2205
Abstract
No abstract availableKeywords
Funding Information
- Research to Prevent Blindness
This publication has 21 references indexed in Scilit:
- Reproducibility of Quantitative Optical Coherence Tomography Subanalysis in Neovascular Age-Related Macular DegenerationInvestigative Ophthalmology & Visual Science, 2007
- Visual Acuity and Fixation Characteristics in Age‐Related Macular DegenerationOptometry and Vision Science, 2007
- Progressive Visual Loss in Subfoveal Exudation in Age-related Macular Degeneration: A Meta-analysis Using Lineweaver-Burke PlotsAmerican Journal of Ophthalmology, 2007
- Triamcinolone Acetonide Inhibits IL-6– and VEGF-Induced Angiogenesis Downstream of the IL-6 and VEGF ReceptorsInvestigative Ophthalmology & Visual Science, 2006
- Evidence of tachyphylaxis associated with salmeterol treatment of chronic obstructive pulmonary disease patientsInternational Journal Of Clinical Practice, 2006
- Inhibitors of Ocular NeovascularizationJAMA, 2005
- The effect of daily use of brimonidine tartrate on the dark-adapted pupil diameterAmerican Journal of Ophthalmology, 2004
- Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degenerationOphthalmology, 2003
- Immunohistochemical distribution of 11β-hydroxysteroid dehydrogenase in human eyeMolecular and Cellular Endocrinology, 2001
- MODELS FOR ASSESSING SCAR TISSUE INHIBITORSRetina, 1985